News

Got $5,000? Here Are 3 Stocks to Buy and Hold for the Long Term

Companies that can tap into, shape, and benefit from powerful industry trends will typically post fantastic growth and deliver strong returns for investors. While it may be tempting to try to

TheMotleyFool

0

Here's Why This Is Now My Single Largest Stock Investment

At the start of 2020, my stock portfolio looked quite a bit different than it does today. I owned mostly "safe" stocks, largely ignoring the fast-growing tech companies that dominate the headlines

TheMotleyFool

0

These 3 Value Stocks Are Absurdly Cheap Right Now

2020 has been a turbulent year for the stock market, but not necessarily a bad one when you consider all that has happened. In fact, the S&P 500 is actually up by about 4% for the year as I'm

TheMotleyFool

0

Can Office Real Estate Rebound After the Pandemic?

Fear is widespread among investors and analysts that the trend toward remote work will increase office vacancies, especially in cities. Other experts still see value in offices and don't necessarily

TheMotleyFool

0

2 Best Cannabis Stocks to Own in 2020

Marijuana stocks are once again at the top of investors' watchlists, after several catalysts recently propelled shares of a slew of industry players. First of all, sales of legalized cannabis

TheMotleyFool

0

Can bluebird bio Recover From Another Major Setback?

Shares of bluebird bio (NASDAQ: BLUE) recently took a pounding after the company's lead candidate hit a snag that investors find all too familiar. The company will no longer be applying for approval

TheMotleyFool

0

Pre-Retirees' Retirement Account Balances Show Many Are in Serious Trouble

Workplace 401(k)s and IRAs are an important source of retirement savings for most Americans. Unfortunately, new data indicates that these retirement account balances are far too low for millions of

TheMotleyFool

0

What's Behind Invitae's Q3 Earnings Beat

What a year it's been for Invitae (NYSE: NVTA). Its shares have skyrocketed well over 180% year to date thanks mainly to its big acquisition of leading genomics analysis company ArcherDX.

Invitae

TheMotleyFool

0

3 Reasons Pfizer's Imminent Upjohn-Mylan Merger Is Great News for Investors

Our experts issued a rare "Double Down" Buy alert on this one stock... Learn more.

A long-awaited deal will soon be done. Pfizer (NYSE: PFE) and Mylan (NASDAQ: MYL) announced last week that the U.S

TheMotleyFool

0

Got $3,000? 3 Great Stocks to Buy Now That Election Day Is Over

What's the best election outcome for investors? It's usually one in which no single party controls both legislative chambers and the presidency. While some votes are still being counted, a divided

TheMotleyFool

0

Trump Will Owe This Much Social Security Tax in 2021

For more than 80 years, Social Security has been laying a financial foundation for our nation's retired workers. More than 46 million retirees receive a payout each month from the program, with more

TheMotleyFool

0

3 Stocks to Buy and Hold for Decades

Imagine it's 2040 instead of 2020. After the year we've had, that's probably going to be a pleasant mental diversion.

Now envision the stocks you bought 20 years earlier and never sold. Which stocks

TheMotleyFool

0

How BioMarin Beat Expectations in Q3

2020 is looking like a year to forget for BioMarin Pharmaceutical (NASDAQ: BMRN). The decision by the Food and Drug Administration (FDA) to not approve Roctavian (valoctocogene roxaparvovec) in

TheMotleyFool

0

Got $500? 3 Great Stocks That Will Make You Richer

If there's a prevailing theme for investors this year, it's volatility. Always present in the stock market, volatility has been especially pronounced in 2020 on the heels of the coronavirus disease

TheMotleyFool

0

This Is Bitcoin's Defining Moment

For more than a decade, bitcoin has been a huge success story. Scorned by skeptics since its inception, the value of the cryptocurrency has gone from less than $0.01 to nearly $15,000. Along the

TheMotleyFool

0